Request Deal Involvement

Perceptive Advisors-backed Arya Sciences Acquisition III completed the merger with Nautilus Biotechnology in a $900m deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Jefferies & Company

financial advisors

Jefferies & Company

Goldman Sachs

financial advisors

Goldman Sachs

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Sodali & Co

commercial advisors

Sodali & Co

Latham & Watkins

legal advisors

Latham & Watkins

Morgan Stanley

financial advisors

Morgan Stanley

TD Cowen

financial advisors

TD Cowen

Wilson Sonsini Goodrich & Rosati

legal advisors

Wilson Sonsini Goodrich & Rosati

or

Principals

ARYA SCIENCES ACQUISITION CORP III

bidder

ARYA SCIENCES ACQUISITION CORP III

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

bidder

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

ALYESKA INVESTMENT GROUP

bidder

ALYESKA INVESTMENT GROUP

CASDIN CAPITAL

bidder

CASDIN CAPITAL

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

BAIN CAPITAL LIFE SCIENCES

bidder

BAIN CAPITAL LIFE SCIENCES

MADRONA VENTURE GROUP

bidder

MADRONA VENTURE GROUP

ANDREESSEN HOROWITZ LLC (A16Z)

bidder

ANDREESSEN HOROWITZ LLC (A16Z)

VULCAN CAPITAL

bidder

VULCAN CAPITAL

PERCEPTIVE ADVISORS LLC

bidder

PERCEPTIVE ADVISORS LLC

NAUTILUS BIOTECHNOLOGY

target

NAUTILUS BIOTECHNOLOGY

ALLY BRIDGE GROUP

bidder

ALLY BRIDGE GROUP

ORBIMED PE

bidder

ORBIMED PE

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Perceptive Advisors-backed Arya Sciences Acquisition III completed the merger with Nautilus Biotechnology in a $900m deal.